Speech Motor Treatment in Cerebral Palsy
Primary Purpose
Cerebral Palsy, Dysarthria
Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
PROMPT
Sponsored by
About this trial
This is an interventional treatment trial for Cerebral Palsy focused on measuring cerebral palsy, dysartria, motor speech treatment, prompt
Eligibility Criteria
Inclusion Criteria:
- child between 2 and 9 years with a diagnosis of CP, with normal to mild intellectual disability and adequate language comprehension skills
- motor speech deficit
Exclusion Criteria:
- utilization of AAC strategies as the only means of communication,
- medical fragility or anatomical malformations affecting speech production preventing the ability to participate in the intervention
Sites / Locations
- IRCCS Fondazione Stella MarisRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
PROMPT Treated
Control
Arm Description
PROMPT treatment, twice a day, for 5 days a week, for 3 consecutive weeks
Usual treatment
Outcomes
Primary Outcome Measures
Verbal Motor Production Assessment for Children (VMPAC)
Standardized motor speech assessment, which includes 5 subscales, where higher scores mean better performance: Global motor control (range 20-0); Focal oromotor control (range 268-0); Sequencing (range 46-0); Connected speech and language (range 45-0); Speech Characteristics (range 7-0)
Phonetic Inventory
motor speech measure
the Intelligibility in Context Scale - Italian version
motor speech measure, range 1-5, where higher scores mean better performances
Viking Speech Scale (VSS)
Ordinal scale for intelligibility, range 1-4, with lower scores corresponding to better performances
Secondary Outcome Measures
kinematic speech motor measures
A kinematic analysis of facial movements during simple speech repetition tasks
Full Information
NCT ID
NCT04189159
First Posted
December 4, 2019
Last Updated
May 18, 2022
Sponsor
IRCCS Fondazione Stella Maris
1. Study Identification
Unique Protocol Identification Number
NCT04189159
Brief Title
Speech Motor Treatment in Cerebral Palsy
Official Title
PROMPT to Improve Speech Motor Abilities in Children With Cerebral Palsy
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2020 (Actual)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
December 31, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IRCCS Fondazione Stella Maris
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Cerebral palsy (CP) is the most frequent cause of motor disability worldwide, with a prevalence of 2-2.5 per 1000 live births. Children with CP may experience a variety of difficulties with communication including speech. Communication impairment has been identified in at least 40% of children with CP, with 36-90% of CP children experiencing motor speech impairment.
The aims of the current project are to test the effectiveness of intensive PROMPT treatment in a group of preschool children with CP and motor speech disorders (dysarthria/apraxia of speech) and to evaluate differences to the intervention response according to CP type, brain lesion severity and white matter integrity of corticospinal tract. We hypothesize that children with CP and motor speech disorders will benefit from 3 weeks of daily administration of PROMPT treatment and show measurable improvement of speech intelligibility on clinical and kinematic assessments, with 3 months stability. Outcome measures will include a standardized speech motor assessment as well as improvement in kinematic speech measures detected by a computerized system. We also hypothesize that children with dyskynetic CP will show more improvement induced by the PROMPT treatment as compared to children with spastic CP. We finally hypothesize that corticospinal microstructural integrity positively impact on intelligibility recovery, with children with better integrity having bigger improvements.
Our study of PROMPT with children with varying types of CP meets current international priorities of testing and implementing effective, earlier interventions, therefore investing in the improvement infant's health based on evidence, as a future investment for individuals and the community.
Detailed Description
Rationale and purpose of research Cerebral palsy (CP) is the most frequent cause of motor disability worldwide, with a prevalence of 2-2.5 per 1000 live births. Several comorbidities characterize the clinical picture of children with CP, such as communication impairment, feeding difficulties, intellectual disability, vision and hearing impairment and epilepsy. Children with CP may experience a variety of difficulties with communication including speech, the development of gesture and facial expression, or receptive and expressive language, including voice production and intelligibility. Communication impairment has been identified in at least 40% of children with CP, with 36-90% of CP children experiencing motor speech impairment. Also, it has also been suggested that some children who do not present explicit dysarthria may have underlying speech motor control deficits. Intelligibility due to motor speech impairments affects activity and participation within various environments, reduces quality of life and increases daily care needs. Dysarthria may also be associated with excessive drooling and swallowing difficulties. Several studies consider compromised speech abilities as an indicator of the need for augmentative and alternative communication to supplement or replace communication. Conversely, CP and early acquired brain injury remain two of the most common medical causes of referral to speech and language therapy. However, little effort has been made in systematically improving speech motor abilities of children with CP by using early, reproducible and targeted intervention strategies. Furthermore, a poor relationship between the motor command and perceptual consequence of the speech movement has been hypothesized as a possible mechanism of speech dysfunction in CP, suggesting a potential therapeutic value of enhancing tactile-kinesthetic input to motor speech abilities of CP children.
Review of literature There are few papers reporting trials on targeted standardized intervention for speech motor deficit in infants or children with CP, with little evidences on treatment effectiveness. In a small group of children aged 3-11 years, it has been suggested that the effect of a speech motor treatment was aligned with the core principles of dynamic systems theory such as PROMPT (Prompts for Restructuring Oral Muscular Phonetic Targets) in changing speech motor patterns of children with CP with proven benefits in intelligibility, documented by kinematic analyses. Several types of CP were included (dyskinetic, spastic unilateral and bilateral). In a group of 7 children with spastic quadriplegia, some outcome of a motor speech treatment originally developed for adults with Parkinson disease were validated, the Lee Silverman Voice Treatment (LSVT LOUD). They also showed changes in white matter integrity supporting behavioral changes.
Research questions/Hypothesis Aim 1: To test the effectiveness of intensive PROMPT treatment in a group of preschool children with CP and motor speech disorders (dysarthria/apraxia of speech).
Aim 2: To evaluate differences to the intervention response according to CP type, brain lesion severity and white matter integrity of corticospinal tract.
Primary Hypothesis: children with CP and motor speech disorders will benefit from 3 weeks of daily administration of PROMPT treatment and show measurable improvement of speech intelligibility on clinical and kinematic assessments, with 3 months stability.
Secondary hypotheses: children with dyskynetic CP will show more improvement induced by the PROMPT treatment as compared to children with spastic CP. Investigators also hypothesize that children with less severe brain lesions will have a higher level of improvement compared to children with more severe brain lesions. Investigators finally hypothesize that corticospinal microstructural integrity positively impact on intelligibility recovery, with children with better integrity having bigger improvements.
Method Investigators plan a randomized trial of PROMPT in children with CP using a wait-list control group. Eligible children will be randomized into either immediate treatment or wait-list-control groups. This design allows every child meeting inclusion criteria to eventually receive the treatment and avoids issues of equipoise. For CP wait-listed controls, the study continues for 3 weeks longer and results into an additional assessment.
Because PROMPT has been shown to be beneficial in several older children with CP, investigators' rational for the design allows for achievement of the RCT data collection and analysis, as well as allow all identified and consented children to receive the intervention.
The participants will include children between 3 and 9 years of age, with a diagnosis of CP and speech motor disorders. Parents will be asked to consent for the children for the participation in the study. All study activities will be carried out in our clinical center setting with a PROMPT trained therapist with appropriate knowledge of clinical research process.
In investigators' studies of rehabilitation with the CP population consent to participate in studies approaches 90%. From investigators' experience and clinical demographics of the center, they were expected 30 patients diagnosed CP with speech difficulties in the requisite age group per year, making possible a design of staggered enrollment of intervention and wait-list-control groups in the RCT. Recruitment will be completed according to the standards of research consent, followed by group randomization, by a team member other than the treating therapist. The assessments will be completed by an experiences SLP, different from the treating therapist.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cerebral Palsy, Dysarthria
Keywords
cerebral palsy, dysartria, motor speech treatment, prompt
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
We plan a randomized trial using a wait-list control group.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
PROMPT Treated
Arm Type
Experimental
Arm Description
PROMPT treatment, twice a day, for 5 days a week, for 3 consecutive weeks
Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual treatment
Intervention Type
Behavioral
Intervention Name(s)
PROMPT
Other Intervention Name(s)
motor speech treatment
Intervention Description
PROMPT treatment is consistent with the principles of motor learning, in that every session includes a blocked pre-practice followed by variable and distributed practice and a gradual, hierarchical increase of complexity. Speech motor goals are integrated in goals for language and functional communication. During a PROMPT session tactile-kinesthetic-proprioceptive inputs are consistently provided, in order to shape speech movements, to give information on sequencing and timing and to introduce constraints for the reduction of degrees of freedom at the articulators' level in favour of motor control.
Primary Outcome Measure Information:
Title
Verbal Motor Production Assessment for Children (VMPAC)
Description
Standardized motor speech assessment, which includes 5 subscales, where higher scores mean better performance: Global motor control (range 20-0); Focal oromotor control (range 268-0); Sequencing (range 46-0); Connected speech and language (range 45-0); Speech Characteristics (range 7-0)
Time Frame
after the end of treatment period (4 weeks from baseline)
Title
Phonetic Inventory
Description
motor speech measure
Time Frame
after the end of treatment period (4 weeks from baseline)
Title
the Intelligibility in Context Scale - Italian version
Description
motor speech measure, range 1-5, where higher scores mean better performances
Time Frame
after the end of treatment period (4 weeks from baseline)
Title
Viking Speech Scale (VSS)
Description
Ordinal scale for intelligibility, range 1-4, with lower scores corresponding to better performances
Time Frame
after the end of treatment period (4 weeks from baseline)
Secondary Outcome Measure Information:
Title
kinematic speech motor measures
Description
A kinematic analysis of facial movements during simple speech repetition tasks
Time Frame
after the end of treatment period (4 weeks from baseline)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
9 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
child between 2 and 9 years with a diagnosis of CP, with normal to mild intellectual disability and adequate language comprehension skills
motor speech deficit
Exclusion Criteria:
utilization of AAC strategies as the only means of communication,
medical fragility or anatomical malformations affecting speech production preventing the ability to participate in the intervention
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Simona Fiori, MD, PhD
Phone
00393288170636
Email
s.fiori@fsm.unipi.it
First Name & Middle Initial & Last Name or Official Title & Degree
Giuseppina Sgandurra, MD, PhD
Phone
0039050886310
Email
g.sgandurra@fsm.unipi.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Simona Fiori, MD, PhD
Organizational Affiliation
IRCCS Stella Maris Foundation
Official's Role
Principal Investigator
Facility Information:
Facility Name
IRCCS Fondazione Stella Maris
City
Marina di Pisa-Tirrenia-Calambrone
State/Province
Toscana
ZIP/Postal Code
56128
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Giovanni Cioni
Phone
050886233
Email
gcioni@fsm.unipi.it
First Name & Middle Initial & Last Name & Degree
Giuseppina Sgandurra
Email
gsgandurra@fsm.unipi.it
12. IPD Sharing Statement
Citations:
PubMed Identifier
15568275
Citation
Whelan MA. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004 Nov 23;63(10):1985-6; author reply 1985-6. No abstract available.
Results Reference
background
PubMed Identifier
27087436
Citation
Barty E, Caynes K, Johnston LM. Development and reliability of the Functional Communication Classification System for children with cerebral palsy. Dev Med Child Neurol. 2016 Oct;58(10):1036-41. doi: 10.1111/dmcn.13124. Epub 2016 Apr 17.
Results Reference
background
PubMed Identifier
27705010
Citation
Boliek CA, Fox CM. Therapeutic effects of intensive voice treatment (LSVT LOUD(R)) for children with spastic cerebral palsy and dysarthria: A phase I treatment validation study. Int J Speech Lang Pathol. 2017 Dec;19(6):601-615. doi: 10.1080/17549507.2016.1221451. Epub 2016 Oct 5.
Results Reference
background
PubMed Identifier
23574478
Citation
Bosanquet M, Copeland L, Ware R, Boyd R. A systematic review of tests to predict cerebral palsy in young children. Dev Med Child Neurol. 2013 May;55(5):418-26. doi: 10.1111/dmcn.12140.
Results Reference
background
PubMed Identifier
17272605
Citation
Chen CY, Liu CY, Su WC, Huang SL, Lin KM. Factors associated with the diagnosis of neurodevelopmental disorders: a population-based longitudinal study. Pediatrics. 2007 Feb;119(2):e435-43. doi: 10.1542/peds.2006-1477.
Results Reference
background
PubMed Identifier
25997757
Citation
Cicchetti D. Neural plasticity, sensitive periods, and psychopathology. Dev Psychopathol. 2015 May;27(2):319-20. doi: 10.1017/S0954579415000012. No abstract available.
Results Reference
background
PubMed Identifier
23656274
Citation
Cockerill H, Elbourne D, Allen E, Scrutton D, Will E, McNee A, Fairhurst C, Baird G. Speech, communication and use of augmentative communication in young people with cerebral palsy: the SH&PE population study. Child Care Health Dev. 2014 Mar;40(2):149-57. doi: 10.1111/cch.12066. Epub 2013 May 9.
Results Reference
background
PubMed Identifier
24750109
Citation
Fiori S, Cioni G, Klingels K, Ortibus E, Van Gestel L, Rose S, Boyd RN, Feys H, Guzzetta A. Reliability of a novel, semi-quantitative scale for classification of structural brain magnetic resonance imaging in children with cerebral palsy. Dev Med Child Neurol. 2014 Sep;56(9):839-45. doi: 10.1111/dmcn.12457. Epub 2014 Apr 19.
Results Reference
background
PubMed Identifier
25813668
Citation
Fiori S, Guzzetta A. Plasticity following early-life brain injury: Insights from quantitative MRI. Semin Perinatol. 2015 Mar;39(2):141-6. doi: 10.1053/j.semperi.2015.01.007.
Results Reference
background
PubMed Identifier
20643795
Citation
Hustad KC, Gorton K, Lee J. Classification of speech and language profiles in 4-year-old children with cerebral palsy: a prospective preliminary study. J Speech Lang Hear Res. 2010 Dec;53(6):1496-513. doi: 10.1044/1092-4388(2010/09-0176). Epub 2010 Jul 19.
Results Reference
background
PubMed Identifier
11995892
Citation
Kennes J, Rosenbaum P, Hanna SE, Walter S, Russell D, Raina P, Bartlett D, Galuppi B. Health status of school-aged children with cerebral palsy: information from a population-based sample. Dev Med Child Neurol. 2002 Apr;44(4):240-7. doi: 10.1017/s0012162201002018.
Results Reference
background
PubMed Identifier
23390172
Citation
Liegeois F, Tournier JD, Pigdon L, Connelly A, Morgan AT. Corticobulbar tract changes as predictors of dysarthria in childhood brain injury. Neurology. 2013 Mar 5;80(10):926-32. doi: 10.1212/WNL.0b013e3182840c6d. Epub 2013 Feb 6.
Results Reference
background
PubMed Identifier
22215036
Citation
McLeod S, Harrison LJ, McCormack J. The intelligibility in Context Scale: validity and reliability of a subjective rating measure. J Speech Lang Hear Res. 2012 Apr;55(2):648-56. doi: 10.1044/1092-4388(2011/10-0130). Epub 2012 Jan 3.
Results Reference
background
PubMed Identifier
26566585
Citation
Mei C, Reilly S, Reddihough D, Mensah F, Pennington L, Morgan A. Language outcomes of children with cerebral palsy aged 5 years and 6 years: a population-based study. Dev Med Child Neurol. 2016 Jun;58(6):605-11. doi: 10.1111/dmcn.12957. Epub 2015 Nov 14.
Results Reference
background
PubMed Identifier
23186066
Citation
Nordberg A, Miniscalco C, Lohmander A, Himmelmann K. Speech problems affect more than one in two children with cerebral palsy: Swedish population-based study. Acta Paediatr. 2013 Feb;102(2):161-6. doi: 10.1111/apa.12076. Epub 2012 Nov 27.
Results Reference
background
PubMed Identifier
24958005
Citation
Novak I. Evidence-based diagnosis, health care, and rehabilitation for children with cerebral palsy. J Child Neurol. 2014 Aug;29(8):1141-56. doi: 10.1177/0883073814535503. Epub 2014 Jun 22.
Results Reference
background
PubMed Identifier
28715518
Citation
Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom-Hernandez J, Cioni G, Damiano D, Darrah J, Eliasson AC, de Vries LS, Einspieler C, Fahey M, Fehlings D, Ferriero DM, Fetters L, Fiori S, Forssberg H, Gordon AM, Greaves S, Guzzetta A, Hadders-Algra M, Harbourne R, Kakooza-Mwesige A, Karlsson P, Krumlinde-Sundholm L, Latal B, Loughran-Fowlds A, Maitre N, McIntyre S, Noritz G, Pennington L, Romeo DM, Shepherd R, Spittle AJ, Thornton M, Valentine J, Walker K, White R, Badawi N. Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy: Advances in Diagnosis and Treatment. JAMA Pediatr. 2017 Sep 1;171(9):897-907. doi: 10.1001/jamapediatrics.2017.1689. Erratum In: JAMA Pediatr. 2017 Sep 1;171(9):919.
Results Reference
background
PubMed Identifier
20813020
Citation
Parkes J, Hill N, Platt MJ, Donnelly C. Oromotor dysfunction and communication impairments in children with cerebral palsy: a register study. Dev Med Child Neurol. 2010 Dec;52(12):1113-9. doi: 10.1111/j.1469-8749.2010.03765.x. Epub 2010 Aug 31.
Results Reference
background
PubMed Identifier
23441834
Citation
Pennington L, Roelant E, Thompson V, Robson S, Steen N, Miller N. Intensive dysarthria therapy for younger children with cerebral palsy. Dev Med Child Neurol. 2013 May;55(5):464-71. doi: 10.1111/dmcn.12098. Epub 2013 Feb 26.
Results Reference
background
PubMed Identifier
27428115
Citation
Pennington L, Parker NK, Kelly H, Miller N. Speech therapy for children with dysarthria acquired before three years of age. Cochrane Database Syst Rev. 2016 Jul 18;7(7):CD006937. doi: 10.1002/14651858.CD006937.pub3.
Results Reference
background
PubMed Identifier
11561033
Citation
Ramig LO, Sapir S, Countryman S, Pawlas AA, O'Brien C, Hoehn M, Thompson LL. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):493-8. doi: 10.1136/jnnp.71.4.493.
Results Reference
background
PubMed Identifier
28750368
Citation
Reed A, Cummine J, Bakhtiari R, Fox CM, Boliek CA. Changes in White Matter Integrity following Intensive Voice Treatment (LSVT LOUD(R)) in Children with Cerebral Palsy and Motor Speech Disorders. Dev Neurosci. 2017;39(6):460-471. doi: 10.1159/000478724. Epub 2017 Jul 28.
Results Reference
background
PubMed Identifier
23025573
Citation
Ward R, Strauss G, Leitao S. Kinematic changes in jaw and lip control of children with cerebral palsy following participation in a motor-speech (PROMPT) intervention. Int J Speech Lang Pathol. 2013 Apr;15(2):136-55. doi: 10.3109/17549507.2012.713393. Epub 2012 Oct 1.
Results Reference
background
PubMed Identifier
24521506
Citation
Ward R, Leitao S, Strauss G. An evaluation of the effectiveness of PROMPT therapy in improving speech production accuracy in six children with cerebral palsy. Int J Speech Lang Pathol. 2014 Aug;16(4):355-71. doi: 10.3109/17549507.2013.876662. Epub 2014 Feb 13.
Results Reference
background
PubMed Identifier
25652139
Citation
Watson RM, Pennington L. Assessment and management of the communication difficulties of children with cerebral palsy: a UK survey of SLT practice. Int J Lang Commun Disord. 2015 Mar-Apr;50(2):241-59. doi: 10.1111/1460-6984.12138. Epub 2015 Feb 4.
Results Reference
background
PubMed Identifier
35794522
Citation
Fiori S, Ragoni C, Podda I, Chilosi A, Amador C, Cipriani P, Guzzetta A, Sgandurra G. PROMPT to improve speech motor abilities in children with cerebral palsy: a wait-list control group trial protocol. BMC Neurol. 2022 Jul 6;22(1):246. doi: 10.1186/s12883-022-02771-6.
Results Reference
derived
Learn more about this trial
Speech Motor Treatment in Cerebral Palsy
We'll reach out to this number within 24 hrs